Millennium Management’s Kazia Therapeutics KZIA Stock Holding History

Millennium Management’s Portfolio KZIA Stock Details KZIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-113	Closed	-$91K	–	3605
2015 Q2	$91K	Buy	+113	New	+$128K	﹤0.01%	3185

Other funds holding KZIA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MWP

MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Millennium Management's KZIA Position: Q3 2015 in Review

Millennium Management sold out of Kazia Therapeutics (KZIA) in Q3 2015, closing a stake of 113 shares — an estimated $91K sold.

Millennium Management first reported a position in KZIA in Q2 2015 and held it in 1 quarter. The position peaked at $91K in Q2 2015. 7 funds tracked by Wall St. Rank hold KZIA as of Q3 2015.

Millennium Management reported no remaining Kazia Therapeutics position as of Q3 2015 after selling out during the quarter.
Millennium Management sold 113 Kazia Therapeutics shares in Q3 2015, an estimated $91K.
Millennium Management first reported a position in Kazia Therapeutics in Q2 2015 and held it in 1 quarter.
Millennium Management's Kazia Therapeutics position peaked at $91K in Q2 2015.
7 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q3 2015.

Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.